Streetbeat News

Products Services

AAPL

Apple Inc.'s top-tier 16-inch MacBook Pro powered by the M3 Max chipset costs $7,199 with maxed-out specifications. This price is equivalent to the combined cost of all the latest Apple products and the world's most expensive French fries, Crème de la Crème Pomme Frites.

Portfolio Pulse from Rounak Jain

October 31, 2023 | 12:54 pm

BABA

NVDA

PDD

Alibaba's stock is trading lower amid struggles in the e-commerce sector and updates to its AI model, Tongyi Qianwen. Nvidia is set to lose billions in revenue from China due to new US sanctions on AI technology. Alibaba's cloud computing arm has launched eight AI models for various industries. Alibaba is also pressuring merchants to offer low prices for its Singles Day event, indicating rivalry with Douyin and PDD Holdings. China's state-backed chip investment fund has invested in a memory chip company, Changxin Xinqiao.

Portfolio Pulse from Anusuya Lahiri

October 31, 2023 | 12:53 pm

AAPL

NVDA

SSNLF

Samsung Electronics reported a Q3 sales decline to $51.3 billion, down from $76.78 trillion a year ago. The company's chip division reported a loss due to AI demand, while its display division, which makes screens for Apple's iPhone 15, saw an increase in operating profit. Samsung's mobile business also posted a profit, aided by new Galaxy Z foldable smartphones. The company plans to increase sales of highly profitable product lines in Q4, focusing on the pricier HBM as a new revenue stream.

Portfolio Pulse from Anusuya Lahiri

October 31, 2023 | 12:49 pm

CTXR

Citius Pharmaceuticals (NASDAQ:CTXR) announced positive results from a preclinical study on LYMPHIR, a combination therapy for solid tumors. The study showed that LYMPHIR, in combination with an anti-PD-1 checkpoint inhibitor, was more effective in treating solid tumors than either therapy alone. The results contributed to the design of two Phase 1 studies currently underway at the University of Pittsburgh and the University of Minnesota. The company believes the results highlight LYMPHIR's potential as a combination therapy, which could open up larger market opportunities.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:47 pm

PETS

PINS

SPRC

SciSparc (SPRC) was granted a patent for its opioid reduction technology, causing its shares to surge by 152%. Pinterest (PINS) shares rose by 19% after reporting better-than-expected Q3 results and issuing guidance. PetMed Express (PETS) shares fell by 28% after its Q2 2024 sales missed estimates.

Portfolio Pulse from ryanfaloona@benzinga.com

October 31, 2023 | 12:46 pm

CAT

Caterpillar's CEO has stated in a conference call that the company is 'very comfortable' with its dealer inventories, which are within the typical range.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:45 pm

CAT

Caterpillar's executive has stated that the company is witnessing continued growth in non-residential construction in North America. However, the CEO also noted a reduction in dealer orders for construction products, which was anticipated.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:44 pm

LEXX

Lexaria Bioscience Corp. (NASDAQ:LEXX) is evaluating its proprietary drug-delivery platform, DehydraTECH, for improved efficacy of GLP-1 drugs. The company began diabetes-related studies last year, which showed reduced blood-sugar levels and lowered body weight. Lexaria is planning to launch new human and animal studies to examine whether DehydraTECH processing can make GLP-1 drugs such as semaglutide even better.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:43 pm

AMGN

An executive from Amgen has stated that they are looking forward to the data from the mid-stage trial of their experimental weight loss drug, which is expected next year.

Portfolio Pulse from Benzinga Newsdesk

October 31, 2023 | 12:42 pm